Key Drivers
- Strong FCF
- Thin net margins
- High intangibles
AIAI Summary
OPCH should be viewed as an execution-dependent turnaround rather than a defensive yield play—strong free cash flow and upbeat FY26 guidance offer upside, but the stock's fate pivots on management materially limiting the Stelara/biosimilar gross-profit drag and demonstrably improving working capital to convert cash into sustainable margin expansion or disciplined buybacks.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong FCF
- •Thin net margins
- •High intangibles
OPCH delivers solid free cash flow and mid‑teens ROE but faces thin net margins, large working‑capital and intangible exposure, and a premium valuation that limits margin of safety.
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Below moving average
- •High-28/low-29 support
OPCH fell about 21% over the last month to $28.16, trading ~9% below its ~$31 last-month moving average—a clear short-term downtrend with nearby resistance in the low–mid $30s and support around the high-$20s.
Sharp ~21% drop from $35.69 to $28.16 over the last month
Sentiment & News
Key News Insights:
- •Q4 in line
- •Institutional buying
- •Sector tailwinds
Option Care matched Q4 EPS expectations while attracting fresh institutional buying and sector attention amid demographic and AI tailwinds.
Steady reported results combined with notable institutional accumulation should support share stability and may draw additional investor interest as outpatient/home-health trends persist
Similar Companies in Healthcare
Other companies in the same sector with AI ratings